Cargando…
IDH1/2 Mutations Predict Shorter Survival in Chondrosarcoma
Background. Recent studies have shown that isocitrate dehydrogenase 1/2 (IDH1/2)- activating mutations occur in a variety of cancers, including acute myeloid leukaemia, gliomas, and chondrosarcomas (CHS)s. The effect of IDH1/2 mutation on overall survival (OS) has not been reported in CHS. The aim o...
Autores principales: | Lugowska, Iwona, Teterycz, Pawel, Mikula, Michal, Kulecka, Maria, Kluska, Anna, Balabas, Aneta, Piatkowska, Magdalena, Wagrodzki, Michal, Pienkowski, Andrzej, Rutkowski, Piotr, Ostrowski, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868167/ https://www.ncbi.nlm.nih.gov/pubmed/29581779 http://dx.doi.org/10.7150/jca.22915 |
Ejemplares similares
-
Limited Practical Utility of Liquid Biopsy in the Treated Patients with Advanced Breast Cancer
por: Niwinska, Anna, et al.
Publicado: (2020) -
Mutational landscape of primary and recurrent Ewing sarcoma
por: Jagodzińska-Mucha, Paulina, et al.
Publicado: (2021) -
New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing
por: Kluska, Anna, et al.
Publicado: (2015) -
Signatures of circulating microRNA in four sarcoma subtypes
por: Kosela-Paterczyk, Hanna, et al.
Publicado: (2020) -
Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection
por: Kulecka, Maria, et al.
Publicado: (2023)